Evolving treatment modalities for immune thrombocytopenia in adults

The management of patients with relapsed or refractory immune thrombocytopenia (ITP) remains challenging for hematologists. While there are a multitude of drugs available, it is largely an individualized management based on patient preferences, side effects, previous treatment received, and response...

Descripción completa

Detalles Bibliográficos
Autores principales: Khadka, Sushmita, Kasireddy, Vineela, Dhakal, Pravash Kumar, Dadiboyina, Chandrakala
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7850435/
https://www.ncbi.nlm.nih.gov/pubmed/33552432
http://dx.doi.org/10.1080/20009666.2020.1843237
_version_ 1783645442718826496
author Khadka, Sushmita
Kasireddy, Vineela
Dhakal, Pravash Kumar
Dadiboyina, Chandrakala
author_facet Khadka, Sushmita
Kasireddy, Vineela
Dhakal, Pravash Kumar
Dadiboyina, Chandrakala
author_sort Khadka, Sushmita
collection PubMed
description The management of patients with relapsed or refractory immune thrombocytopenia (ITP) remains challenging for hematologists. While there are a multitude of drugs available, it is largely an individualized management based on patient preferences, side effects, previous treatment received, and responses to them, comorbidities and cost associated with the treatment. We hereby review the newer approaches in the treatment of ITP.
format Online
Article
Text
id pubmed-7850435
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-78504352021-02-05 Evolving treatment modalities for immune thrombocytopenia in adults Khadka, Sushmita Kasireddy, Vineela Dhakal, Pravash Kumar Dadiboyina, Chandrakala J Community Hosp Intern Med Perspect Review Article The management of patients with relapsed or refractory immune thrombocytopenia (ITP) remains challenging for hematologists. While there are a multitude of drugs available, it is largely an individualized management based on patient preferences, side effects, previous treatment received, and responses to them, comorbidities and cost associated with the treatment. We hereby review the newer approaches in the treatment of ITP. Taylor & Francis 2021-01-26 /pmc/articles/PMC7850435/ /pubmed/33552432 http://dx.doi.org/10.1080/20009666.2020.1843237 Text en © 2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group on behalf of Greater Baltimore Medical Center. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Khadka, Sushmita
Kasireddy, Vineela
Dhakal, Pravash Kumar
Dadiboyina, Chandrakala
Evolving treatment modalities for immune thrombocytopenia in adults
title Evolving treatment modalities for immune thrombocytopenia in adults
title_full Evolving treatment modalities for immune thrombocytopenia in adults
title_fullStr Evolving treatment modalities for immune thrombocytopenia in adults
title_full_unstemmed Evolving treatment modalities for immune thrombocytopenia in adults
title_short Evolving treatment modalities for immune thrombocytopenia in adults
title_sort evolving treatment modalities for immune thrombocytopenia in adults
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7850435/
https://www.ncbi.nlm.nih.gov/pubmed/33552432
http://dx.doi.org/10.1080/20009666.2020.1843237
work_keys_str_mv AT khadkasushmita evolvingtreatmentmodalitiesforimmunethrombocytopeniainadults
AT kasireddyvineela evolvingtreatmentmodalitiesforimmunethrombocytopeniainadults
AT dhakalpravashkumar evolvingtreatmentmodalitiesforimmunethrombocytopeniainadults
AT dadiboyinachandrakala evolvingtreatmentmodalitiesforimmunethrombocytopeniainadults

Ejemplares similares